Navigation Links
Changing Paradigms in Hereditary Angioedema: A Focus on Prompt Diagnosis and New Therapies
Date:3/17/2009

Complimentary Continuing Education Lecture for Healthcare Professionals

VOORHEES, N.J., March 17 /PRNewswire/ -- Hereditary angioedema (HAE) is estimated to afflict 10,000 people in the United States each year. Patients with HAE suffer from recurrent attacks of intense localized edema involving the skin, airway, and visceral organs. Left untreated, most patients will suffer at least one acute attack per month. Chronic therapy with attenuated androgens or plasmin inhibitors has been the mainstay of therapy. However, many new therapies are on the horizon, offering hope to thousands who suffer from this debilitating disease.

To address the need for current education on HAE, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring complimentary continuing education lectures at institutions across the United States. This continuing education activity, titled Changing Paradigms in Hereditary Angioedema: A Focus on Prompt Diagnosis and New Therapies, is supported by an educational grant from ViroPharma Incorporated and is accredited for physicians, nurses, and pharmacists.

The faculty for these lectures comprises experts in immunology and HAE from leading medical institutions. The chairperson is Bruce L. Zuraw, MD, Professor of Medicine and Chief of the Section of Allergy and Immunology at the University of California School of Medicine in San Diego, CA.

Healthcare professionals can visit www.RMEI.com, e-mail HAELectures@RMEI.com, or phone toll-free (877) 547-5642 to schedule a lecture at their institution.

"Quality continuing education is vital to developing and increasing knowledge and skills and enhancing patient care," says Robert Michael Educational Institute LLC President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, accredited and non-accredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit www.RMEI.com.


'/>"/>
SOURCE Robert Michael Educational Institute LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
2. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
3. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
4. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
5. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
6. Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
9. Nations Foremost Health Care Leaders Kick Off Summit Focused on Zero-Tolerance Approach to Hospital-Acquired Infections
10. Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A
11. New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , February 23, 2017 ... report on the global market for intraoperative imaging, ... presently valued at US$ 513.9 million. According to ... keep surging on the grounds of increasing adoption ... the field of diagnostic imaging for neurosurgeries. The ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Cardiac Prosthetic Devices ... over the next decade to reach approximately $8.9 billion by 2025. ... for all the given segments on global as well as regional ...
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
Breaking Medicine Technology:
(Date:2/23/2017)... Cranbury, NJ (PRWEB) , ... February 23, 2017 ... ... Cure®, the pre-eminent publication and community for those in the fight against cancer, ... was important in their success. HRA will release top-line findings in a ...
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and only nursing quality ... conference – Empowerment, Value and Collaboration – in Seattle, WA on October 23, 2017. ... Mason Health System in Seattle since 2000. In addition to his role at Virginia ...
(Date:2/23/2017)... ... February 23, 2017 , ... HealthPostures, the desk for standing ... sit stand solutions representative to the Minneapolis Home and Garden Show which is being ... that is garnering national attention is the Minneapolis Convention Center. , From its ...
(Date:2/22/2017)... East Setauket, New York (PRWEB) , ... February ... ... the main floor entrance and lobby of a new healthcare contact center in ... gleaming results. , One of the nation’s largest healthcare systems recently invested $51 ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem cell therapy ... The technology is so cutting edge, in fact, the U.S. Food and Drug ... procedures. However, successful patient outcomes in certain clinical stem cell procedures have shown ...
Breaking Medicine News(10 mins):